Bioequivalence Study of Two Products of Apixaban 5mg Tablets in Healthy, Adult, Human Subjects

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2023
To compare the bioavailability and characterize the pharmacokinetic profile of the sponsor\'s test product relative to that of reference product after single oral dose administration in normal, healthy, adult, human subjects under fasting condition and to assess the bioequivalence.
Epistemonikos ID: 75c948e8ed01c7496d228d0b083a33d600d3a1c6
First added on: May 15, 2024